Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20209385rdf:typepubmed:Citationlld:pubmed
pubmed-article:20209385lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:20209385lifeskim:mentionsumls-concept:C0036126lld:lifeskim
pubmed-article:20209385lifeskim:mentionsumls-concept:C0011306lld:lifeskim
pubmed-article:20209385lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:20209385lifeskim:mentionsumls-concept:C1518613lld:lifeskim
pubmed-article:20209385lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:20209385pubmed:dateCreated2010-3-8lld:pubmed
pubmed-article:20209385pubmed:abstractTextLive attenuated bacterial vectors, such as Salmonella typhimurium, have shown promise as delivery vehicles for DNA. We have examined two new strains of S. typhimurium and their impact on dendritic cell maturation (CD12-sifA/aroC mutant and WT05-ssaV/aroC, both in TML background). Strain WT05 matured dendritic cells in a more efficient way; caused higher release of cytokines TNF-alpha, IL-12, IL-1beta; and was efficient for gene transfer. These findings suggest that the genetic background of the attenuation can influence the pattern of inflammatory immune response to Salmonella infection.lld:pubmed
pubmed-article:20209385pubmed:languageenglld:pubmed
pubmed-article:20209385pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20209385pubmed:citationSubsetIMlld:pubmed
pubmed-article:20209385pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20209385pubmed:statusMEDLINElld:pubmed
pubmed-article:20209385pubmed:issn1537-744Xlld:pubmed
pubmed-article:20209385pubmed:authorpubmed-author:PandhaHardevHlld:pubmed
pubmed-article:20209385pubmed:authorpubmed-author:JohnJustinJlld:pubmed
pubmed-article:20209385pubmed:authorpubmed-author:MichaelAgnies...lld:pubmed
pubmed-article:20209385pubmed:authorpubmed-author:MeyerBrendanBlld:pubmed
pubmed-article:20209385pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20209385pubmed:volume10lld:pubmed
pubmed-article:20209385pubmed:ownerNLMlld:pubmed
pubmed-article:20209385pubmed:authorsCompleteYlld:pubmed
pubmed-article:20209385pubmed:pagination393-401lld:pubmed
pubmed-article:20209385pubmed:meshHeadingpubmed-meshheading:20209385...lld:pubmed
pubmed-article:20209385pubmed:meshHeadingpubmed-meshheading:20209385...lld:pubmed
pubmed-article:20209385pubmed:meshHeadingpubmed-meshheading:20209385...lld:pubmed
pubmed-article:20209385pubmed:meshHeadingpubmed-meshheading:20209385...lld:pubmed
pubmed-article:20209385pubmed:meshHeadingpubmed-meshheading:20209385...lld:pubmed
pubmed-article:20209385pubmed:meshHeadingpubmed-meshheading:20209385...lld:pubmed
pubmed-article:20209385pubmed:meshHeadingpubmed-meshheading:20209385...lld:pubmed
pubmed-article:20209385pubmed:meshHeadingpubmed-meshheading:20209385...lld:pubmed
pubmed-article:20209385pubmed:meshHeadingpubmed-meshheading:20209385...lld:pubmed
pubmed-article:20209385pubmed:year2010lld:pubmed
pubmed-article:20209385pubmed:articleTitleActivation and genetic modification of human monocyte-derived dendritic cells using attenuated Salmonella typhimurium.lld:pubmed
pubmed-article:20209385pubmed:affiliationPostgraduate Medical School-Oncology, University of Surrey, Manor Park, Guildford, UK. a.michael@surrey.ac.uklld:pubmed
pubmed-article:20209385pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20209385pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed